Kolinpharma S.p.A.

BIT:KIP Voorraadrapport

Marktkapitalisatie: €15.9m

Kolinpharma Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Rita Petrelli

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur3.8yrs

Recente managementupdates

Recent updates

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

Jun 17
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Dec 01
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

Aug 25
An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Jun 08
We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

May 21
Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

May 03
Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

Apr 13
Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Feb 20
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Dec 28
Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Nov 22
These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

CEO

Rita Petrelli

no data

Tenure

Dr. Rita Paola Petrelli is the Co-Founder, Chairwoman of The Board, Chief Executive Officer and Chief Financial Officer of Kolinpharma S.p.A. Dr. Petrelli is chartered accountant, auditor and technical-leg...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Rita Petrelli
Co-Founderno datageen gegevensgeen gegevens
Massimo Mantella
CEO & Director4.4yrsgeen gegevensgeen gegevens
Francesco Spano
Independent Directorno datageen gegevensgeen gegevens
Pierluigi Pipolo
Chairman of the Board of Statutory Auditors3.8yrsgeen gegevensgeen gegevens
Giannunzio Corazza
Non-Executive Directorno datageen gegevensgeen gegevens
Edoardo Ferragina
Non-Executive Directorno datageen gegevensgeen gegevens
Maurizio Altini
Independent Directorno datageen gegevensgeen gegevens
Giulio Centemero
Standing Auditor3.8yrsgeen gegevensgeen gegevens
Roberto Giannella
Standing Auditor3.8yrsgeen gegevensgeen gegevens

3.8yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van KIP wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).